RENOWNED PHARMACEUTICAL STRATEGIST, MERV TURNER SEES GREAT PROMISE IN AGT’S EMERGING GENE THERAPY AND JOINS MANAGEMENT TO HELP GUIDE PRODUCTS TO COMMERCIALIZATION ROCKVILLE, MARYLAND (June 7, 2016) – American Gene Technologies International, Inc. (AGT) today announced the appointment of Dr. Mervyn Turner as chairman of the company’s scientific advisory board. Turner has more than 30 years of experience in the… [Read More]
ADDITION OF JONATHAN OTTERSTATTER SIGNALS ADDITIONAL MOMENTUM FOR GENE THERAPY PIONEERS ROCKVILLE, MARYLAND (May 24, 2016) – American Gene Technologies International, Inc. (AGT) today announced the appointment of Jonathan (Jon) Otterstatter to its board of directors. Otterstatter is co-founder, president and CEO of Preventice, Inc., and is a proven leader in the development of technological innovations that lead to broad-based… [Read More]
JERRY VOCKLEY, MD, PHD COLLABORATES WITH AGT ON PHENYLKETONURIA (PKU) ROCKVILLE, Maryland. (May 13, 2016) – American Gene Technologies International, Inc. (AGT) today announced its collaboration with Jerry Vockley, MD, PhD, chief of the Division of Medical Genetics at Children’s Hospital of Pittsburgh of the University of Pittsburgh Medical Center and Cleveland Family Professor of Pediatric Research at the University of Pittsburgh… [Read More]
Subscribe to our newsletter to keep up to date with all the latest news about AGT!
Send this to a friend